Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy

Sara Conti, Pietro Ferrara, Giampiero Mazzaglia, Marco I. D'Orso, Roberta Ciampichini, Carla Fornari, Fabiana Madotto, Michele Magoni, Giuseppe Sampietro, Andrea Silenzi, Claudio V. Sileo, Alberto Zucchi, Giancarlo Cesana, Lamberto Manzoli, Lorenzo G. Mantovani
ERJ Open Research 2020 6: 00458-2020; DOI: 10.1183/23120541.00458-2020
Sara Conti
1Center for Public Health Research, University of Milano – Bicocca, Monza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sara Conti
Pietro Ferrara
1Center for Public Health Research, University of Milano – Bicocca, Monza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pietro Ferrara
  • For correspondence: p_ferrara@alice.it
Giampiero Mazzaglia
1Center for Public Health Research, University of Milano – Bicocca, Monza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco I. D'Orso
1Center for Public Health Research, University of Milano – Bicocca, Monza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberta Ciampichini
2Health Protection Agency of Bergamo (ATS Bergamo), Bergamo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla Fornari
1Center for Public Health Research, University of Milano – Bicocca, Monza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiana Madotto
1Center for Public Health Research, University of Milano – Bicocca, Monza, Italy
3Value-based Healthcare Unit, IRCCS Multimedica, Sesto San Giovanni, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele Magoni
4Health Protection Agency of Brescia (ATS Brescia), Brescia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuseppe Sampietro
2Health Protection Agency of Bergamo (ATS Bergamo), Bergamo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Silenzi
4Health Protection Agency of Brescia (ATS Brescia), Brescia, Italy
5Center for Leadership in Medicine Research and Studies, Università Cattolica del Sacro Cuore, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio V. Sileo
4Health Protection Agency of Brescia (ATS Brescia), Brescia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Zucchi
2Health Protection Agency of Bergamo (ATS Bergamo), Bergamo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giancarlo Cesana
1Center for Public Health Research, University of Milano – Bicocca, Monza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lamberto Manzoli
6Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo G. Mantovani
1Center for Public Health Research, University of Milano – Bicocca, Monza, Italy
3Value-based Healthcare Unit, IRCCS Multimedica, Sesto San Giovanni, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background The real impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on overall mortality remains uncertain as surveillance reports have attributed a limited number of deaths to novel coronavirus disease 2019 (COVID-19) during the outbreak. The aim of this study was to assess the excess mortality during the COVID-19 outbreak in highly impacted areas of northern Italy.

Methods We analysed data on deaths that occurred in the first 4 months of 2020 provided by the health protection agencies (HPAs) of Bergamo and Brescia (Lombardy), building a time-series of daily number of deaths and predicting the daily standardised mortality ratio (SMR) and cumulative number of excess deaths through a Poisson generalised additive model of the observed counts in 2020, using 2019 data as a reference.

Results We estimated that there were 5740 (95% credible set (CS) 5552–5936) excess deaths in the HPA of Bergamo and 3703 (95% CS 3535–3877) in Brescia, corresponding to a 2.55-fold (95% CS 2.50–2.61) and 1.93 (95% CS 1.89–1.98) increase in the number of deaths. The excess death wave started a few days later in Brescia, but the daily estimated SMR peaked at the end of March in both HPAs, roughly 2 weeks after the introduction of lockdown measures, with significantly higher estimates in Bergamo (9.4, 95% CI 9.1–9.7).

Conclusion Excess mortality was significantly higher than that officially attributed to COVID-19, disclosing its hidden burden likely due to indirect effects on the health system. Time-series analyses highlighted the impact of lockdown restrictions, with a lower excess mortality in the HPA where there was a smaller delay between the epidemic outbreak and their enforcement.

Abstract

This study identifies another important element to research on #SARSCoV2 and provides actionable strategies to quantify the excess mortality due to #COVID19 spread, which has public health and research implications to minimise the disease impact https://bit.ly/3jbKXAW

Introduction

As the novel coronavirus disease 2019 (COVID-19) has continued to spread internationally since the beginning of the outbreak in December 2019, one of the most relevant public health concerns has been its mortality rate [1, 2].

Italy is among the countries with the highest number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, reaching >240 000 confirmed cases and around 35 000 deaths in late June 2020 [3]. According to the epidemiological bulletin of June 25, 2020 of the Italian National Institute of Health, patients who died of COVID-19 had a median age of 82 years, while the median age of subjects who tested positive for SARS-CoV-2 infection was 62 years [4, 5]. Surveillance data also suggested that the principal risk factors for mortality in COVID-19 patients were older age, male sex and concomitant conditions [4, 6–8].

Current estimates of the case fatality ratio (CFR) vary considerably from one country to another, likely due to differences in age distribution and health status of the population. There is also general consensus that CFR variability may be explained by inaccurate estimates of the number of people who are infected with SARS-CoV-2. Asymptomatic cases of COVID-19, patients with mild symptoms or individuals who have been misdiagnosed could be omitted from the denominator, leading to its underestimation and thus overestimation of the CFR [1, 9]. As a consequence, CFRs do not currently provide reliable figures to assess the real impact of COVID-19 on a country-based mortality burden [10–12].

Moreover, early research assessed that the mortality burden during the first phase of the spread of COVID-19 in Italy is underestimated, because epidemiological surveillance reports have been attributing only a limited number of all deaths to COVID-19 [1, 2, 13, 14], suggesting that the SARS-CoV-2 epidemic had a bigger impact on overall mortality by direct and indirect effects [1, 2]. Direct effects might include a significant proportion of people who would eventually die from the disease before the diagnosis was made; indirect effects might involve the patient's comorbidity status, as well as the disproportionate hospital overload and severe shortage of healthcare resources in the most affected areas of the country [2, 13]. Analyses on mortality data published by the Italian Institute of Statistics (ISTAT) found increased standardised mortality ratios across different areas of the country in the first weeks of the COVID-19 epidemic. This excess mortality was found to be spread across the northern Italian regions [2]. Lombardy registered the biggest COVID-19 outbreak in Italy (and thus in Europe), accounting for >94 000 cases [3], and some of its provinces – including Bergamo and Brescia – were hit hardest in terms of the death toll during the peak epidemic weeks [13, 14].

Scarce evidence is available on excess overall mortality during the outbreak using population-based direct empirical observations and very little has been published on the time-course of this excess.

Based on these considerations, we decided to conduct a retrospective analysis of mortality data from a densely populated vast geographical area of northern Italy in the first 4 months of 2020, with the aim of describing the magnitude and time-course of the entire cycle of the excess mortality associated with the COVID-19 outbreak and investigating the role of lockdown measures in the mitigation of the disease impact on the general mortality.

Methods

Study population

The Lombardy region, the epicentre of the Italian SARS-CoV-2 outbreak, is served by eight local health protection agencies (HPAs), which cover mutually exclusive areas of the region.

We focused on all inhabitants of the HPAs of Bergamo and Brescia, where the outbreak magnitude has been particularly intense [13, 14].

Study design and data sources

Italy has a tax-funded, universal coverage National Health System that is organised at three levels: national, regional and local. In Lombardy, the local HPAs are primarily responsible for collecting healthcare information (e.g. inpatient and outpatient treatments), including the mortality data of all inhabitants under their jurisdiction [15].

We carried out a longitudinal retrospective time-series study on the overall mortality traced in these standardised healthcare regional administrative databases.

To accomplish the study objectives, we retrieved data on all-cause deaths that occurred between 1 January and 30 April in the years 2020 and 2019, the latter to be used as a reference period. For each deceased subject we linked the unique identification code in the mortality database with demographic information (i.e. age at death and sex).

We chose 2019 as a reference, because we observed that the seasonality of the flu outbreak, which is one of the drivers of variations in mortality during winter, was similar to that observed in 2020 up to the beginning of the COVID outbreak [16]; during previous years, peaks occurred in different periods. Therefore, we hypothesise that 2019 approximates the expected situation in 2020.

Statistical analysis

We compared the age and sex distribution among the deceased in 2019 and 2020 using Chi-squared tests and the number of daily deaths using the Wilcoxon rank-sum test.

We compiled the time-series of the number of observed daily deaths during January to April in 2019 and 2020 for each HPA. Based on these time-series, and considering that the population of each HPA remained stable from 2019 to 2020 (HPA Brescia: from 1 089 602 to 1 097 648; HPA Bergamo: from 1 160 374 to 1 163 243), we computed the expected daily number of deaths for 2020 as the average daily number of deaths that occurred in 2019.

In order to assess the magnitude and time-course of the mortality variation during the SARS-CoV-2 outbreak, we built a Poisson generalised additive model, with the daily death count during 2020 as the outcome, and the HPA, a non-linear function of the date and the number of expected deaths as the predictors.

In detail, the model was:Embedded Image where Embedded Image is the observed number of deaths during the i-th day in j-th HPA, Embedded Image is the daily expected number of deaths in the j-th HPA, and it is held fixed for each i-th day, Embedded Imageis a categorical variable indicating the HPA where the number of deaths was measured in the i-th day, and Embedded Image is a thin plate regression spline of the calendar date [17]. The term Embedded Image indicates that a separate spline is fitted for each HPA, allowing for the estimation of a different epidemic time-course in the two areas. The use of the constant Embedded Image as an offset allows direct modelling of the daily observed/expected ratio of mortality, that is the standardised mortality ratio (SMR), instead of the daily counts, predicting both the estimated number of daily deaths and the estimated SMR [18, 19].

Therefore, based on the model results, we first predicted the SMR for each day of 2020 together with its 95% confidence interval. Thereafter, using the method reported by Rivera et al. [20], we estimated the cumulative number of excess deaths, as compared to 2019, and their correlated 95% credible sets (CS), which similarly to confidence interval synthesise the precision of the estimates but based on Bayesian methods. Finally, we expressed the excess in term of an n-fold increase in the cumulative number of deaths, using 2019 cumulative number of deaths as the reference.

We replicated the whole analysis stratifying by sex and by age, categorised as: <60 years, 60–69 years, 70–79 years, 80–89 years and 90+ years.

All analyses were carried out with statistical software SAS version 9.4 (SAS Institute, Cary, NC, USA) and R version 4.0.0 (R Project for Statistical Computing, www.R-project.org).

Results

During the first 4 months of 2020, 17 099 deaths were registered among the residents of the two HPAs of Bergamo and Brescia, as compared to 7592 in 2019 (table 1). In both provinces, the crude number of deaths increased by >90%. Overall, the daily average number of deaths rose significantly from 63 (sd: 10.7) to 141 (sd: 129.8), with a steeper wave of the cumulative time-series analysis in the area of Bergamo (figure 1).

View this table:
  • View inline
  • View popup
TABLE 1

Characteristics of the deceased over the period 1 January to 30 April 2020, stratified by health protection agency (HPA); comparison between 2020 and 2019

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Comparison of 2020 and 2019 cumulative daily counts of death from 1 January to 30 April, stratified by health protection agency (HPA).

The trends in the estimated daily SMR confirm the substantial differences in the two HPAs for both sexes and for all age-classes older than 60 years (figure 2). The overall daily estimated SMR peaked at 9.4 (95% CI 9.1–9.7) in Bergamo province and at 5.6 (95% CI 5.4–5.8) in Brescia. The highest SMRs were observed among the elderly, peaking in the age-class 70–79: 12.7 (95% CI 11.9–13.5) in Bergamo; 7.3 (95% CI 6.8–7.9) in Brescia.

FIGURE 2
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2

Predicted standardised mortality ratio (SMR) from 1 January to 30 April 2020. Results from the overall analysis and from analyses stratified by age or sex, by health protection agency (HPA).

Overall, during the SARS-CoV-2 outbreak we estimated 5740 (95% CS 5552–5936) excess deaths in the area of Bergamo and 3703 (95% CS 3535–3877) in Brescia, corresponding to a 2.55-fold (95% CS 2.50–2.61) and 1.93-fold (95% CS 1.89–1.98) increase in the number of cumulative deaths (table 2; figure 3).

View this table:
  • View inline
  • View popup
TABLE 2

Estimated cumulative excess deaths and relative increase as compared to 2019, over the period 1 January to 30 April 2020, stratified by health protection agency (HPA), age or sex

FIGURE 3
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3

Estimated cumulative excess deaths and percentage increase compared to 2019, over the period 1 January to 30 April 2020, stratified by health protection agency (HPA) and age or sex.

Restricting the analyses for the months of March and April, the estimated number of excess deaths was 5719 (95% CS 5556–5892) in Bergamo and 3820 (95% CS 3676–3967) in Brescia, representing virtually the whole excess mortality of the entire 2020 analysed period (table 3). This is confirmed by crude rates (supplementary table S1): observed rates over the months of January and February during 2020 were comparable to those of 2019, if not slightly lower. The differential increase across sexes and age-classes was similar in the two provinces, but higher in Bergamo: in the age-class 70–79, the number of cumulative deaths increased by 5.05-fold (95% CS 4.83–5.28), compared to 2.18-fold (95% CS 1.96–2.44) among the youngest.

View this table:
  • View inline
  • View popup
TABLE 3

Estimated cumulative excess deaths and relative increase as compared to 2019, over the period 1 March to 30 April 2020, stratified by health protection agency (HPA), age or sex

Observing the time-series of the daily number of deaths (figure 4), the excess death wave started earlier in the area of Bergamo, roughly 1 week after the detection of the first COVID-19 case in Lombardy (February 21, 2020), and a few days later in the area of Brescia. In both areas, the excess death wave started before the introduction of lockdown measures (March 7, 2020), and the peaks were observed between March 20 and March 25, 2020, roughly 2 weeks after the introduction of lockdown measures, returning to pre-epidemic levels by the end of April.

FIGURE 4
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4

Time-series of daily number of deaths, stratified by health protection agency (HPA). a) 21 February: first confirmed case in Lombardy; b) 22 February: lockdown and quarantine for 11 municipalities; c) 25 February: schools closed and crowd restrictions in six northern regions; d) 4 March: schools closed and crowd restrictions extended to the whole country, e) 7 March: lockdown and quarantine for Lombardy and 14 provinces, f) 11 March: lockdown and quarantine extended to the whole country.

Discussion

This retrospective observational study, based upon the complete data of two Italian HPAs where the outbreak was particularly intense, evaluated the temporal trend of all-cause mortality during the COVID-19 outbreak, describing its complete cycle using real world direct empirical observations.

During the 4-month period of study, we estimated 9443 excess deaths in the areas covered by the HPAs of Bergamo and Brescia, corresponding to a 2.2-fold increase in number of excess deaths as compared to those recorded in the same period of 2019, with a trend that showed a rapid rise starting 10 days after the first case of COVID-19 in the region. These results exceed by far the number of deaths officially attributed to the disease in the two HPAs, which registered 2973 and 2295 deaths in Bergamo and Brescia, respectively, as of 30 April 2020.

It is unlikely that the large increase in number of deaths is solely attributable to conditions other than COVID-19, which affected mortality directly and potentially also indirectly, e.g. through healthcare facilities being overwhelmed and delayed care for time-dependent conditions, such as stroke, myocardial infarction, etc. [2, 21]. Indeed, we observed that all excess deaths occurred in March and April, after the beginning of the disease outbreak, in line with preliminary findings from March only that the overall mortality did not increase in Italian provinces with low rates of infection [13].

Even though the two HPAs are adjacent, the spike in the daily number of deaths started a few days earlier in Bergamo than in Brescia, ∼2 weeks before the introduction of lockdown restrictions. These few days may have been crucial: although the waves had similar shapes, the province of Bergamo showed a significantly and substantially higher increase in mortality (2.55-fold) compared with Brescia (1.93-fold). These findings suggest that the national and local restrictions may have had a massive impact, resulting in a less steep wave in the time-series of the daily number of deaths in Brescia, where virus circulation was delayed. Moreover, in both HPAs we observed significant excess in mortality for 8 weeks, with a peak 4 weeks after the start of the epidemic wave, and an overlapping descending phase. These trends indicated that the length of the excess death period may not be dependent only on the circulation of infection, which is correlated to overall SMR, suggesting that other factors might have influenced the overall mortality in both areas. One hypothesis can be identified in the emergency measures taken during the epidemic phase, such as activation of Special Continuity Assistance Units, a primary care medical home service dedicated to COVID-19 patients, or the construction of field hospitals, which lessened the overload experienced by healthcare facilities in both areas [22, 23].

Confirming previous findings, we observed an increased risk of death among males and the elderly [6–8, 24]. Overall, the 70–79 years age group was the most affected in terms of cumulative deaths, although in COVID-19 patients the highest risk of death was observed among those aged 80 years or more [4]. The discrepancy might be due to a lower infection rate among the oldest, the mobility and social contacts of whom are frequently reduced. Noteworthy, we found a weaker excess mortality in nonagenarians than in younger elderly groups, possibly explained by the healthy survivor effect as well as a less clear-cut direct and indirect impact of COVID-19 in those age-classes in which the underlying functional status is a more significant predictor of all-cause mortality than acute life-threatening conditions [25]. Moreover, demographic characteristics of the population may have contributed to the shape of the curves, with the distribution of the elderly Italian population posing a challenge in reducing the impact of mortality due to the epidemic.

The strengths of the study include the use of administrative databases within a universal coverage system on an unselected population of residents with complete knowledge of vital status, within an area where the outbreak has been particularly strong, and the virus circulated long before the enforcement of lockdown measures. Also, the analysis did not focus only on deaths classified as due to COVID-19, thereby avoiding underestimating the number of deaths at the beginning of the epidemic, when only a selected sample of patients underwent COVID-19 testing. Indeed, our estimates provide inferential estimates of excess deaths and SMRs, based on flexible models that could be easily reproducible in other geographical areas. This is the first study describing the complete cycle of the outbreak, from the first cases to the baseline risk of death using regression. This also allows the comparison of the excess death waves between two geographical areas, providing an initial description of how the timing of lockdown measures can ultimately affect overall mortality. Finally, this research expressed robust data for evaluating the effectiveness of the epidemic response and for providing measures to inform policymakers on ending restrictive lockdown.

Some limitations should also be considered when interpreting the results. First, while accuracy is preserved, the precision of the estimated excess deaths is affected by the average number of daily events, decreasing in the subgroups that have low daily frequencies of death (e.g., the youngest age-class). Second, the reference level is computed based on 2019 only: using a longer time-window could define the reference level better. However, trends in mortality within these areas proved to be very stable during the last few years [26].

In conclusion, we documented a significant increase in the overall mortality during the first months of 2020, particularly March and April, indicating that the COVID-19 outbreak had a substantially larger impact than official estimates. Time-series analyses suggest that the national and local restrictions had a massive effect, providing a considerable reduction of COVID-19 burden. Furthermore, this study may serve as a model for country-based estimations of the overall (direct and indirect) impact of the COVID-19 epidemic on population mortality.

Supplementary material

Supplementary Material

Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

TABLE S1 Crude rates over the period January 1st to April 30th 2020 in the two HPAs, overall and stratified by sex and/or age class 00458-2020.tableS1

Footnotes

  • This article has supplementary material available from openres.ersjournals.com.

  • Conflict of interest: S. Conti has nothing to disclose.

  • Conflict of interest: P. Ferrara has nothing to disclose.

  • Conflict of interest: G. Mazzaglia has nothing to disclose.

  • Conflict of interest: M.I. D'Orso has nothing to disclose.

  • Conflict of interest: R. Ciampichini has nothing to disclose.

  • Conflict of interest: C. Fornari has nothing to disclose.

  • Conflict of interest: F. Madotto has nothing to disclose.

  • Conflict of interest: M. Magoni has nothing to disclose.

  • Conflict of interest: G. Sampietro has nothing to disclose.

  • Conflict of interest: A. Silenzi has nothing to disclose.

  • Conflict of interest: C.V. Sileo has nothing to disclose.

  • Conflict of interest: A. Zucchi has nothing to disclose.

  • Conflict of interest: G. Cesana has nothing to disclose.

  • Conflict of interest: L. Manzoli has nothing to disclose.

  • Conflict of interest: L.G. Mantovani has nothing to disclose.

  • Received July 2, 2020.
  • Accepted July 10, 2020.
  • Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Banerjee A,
    2. Pasea L,
    3. Steve Harris S, et al.
    Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet 2020; 395: 1715–1725. doi:10.1016/S0140-6736(20)30854-0
    OpenUrlCrossRefPubMed
  2. ↵
    1. Conti S,
    2. Ferrara P,
    3. Fornari C, et al.
    Estimates of the initial impact of COVID-19 epidemic on overall mortality: evidence from Italy. ERJ Open Res 2020; 6: 00179-2020. doi:10.1183/23120541.00179-2020
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Dipartimento della Protezione Civile
    . COVID-19 Italia – Monitoraggio della situazione. www.opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1 Date last accessed: July 2, 2020. Date last updated: July 2, 2020.
  4. ↵
    1. Istituto Superiore di Sanità
    . Caratteristiche dei pazienti deceduti positivi all'infezione da SARS-CoV-2 in Italia. www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_25_giugno.pdf Date last accessed: July 2, 2020.
  5. ↵
    1. Istituto Superiore di Sanità
    . Sorveglianza integrata COVID-19. www.epicentro.iss.it/coronavirus/sars-cov-2-sorveglianza-dati Date last accessed: July 2, 2020. Date last updated: June 25, 2020.
  6. ↵
    1. Zhou F,
    2. Yu T,
    3. Du R, et al.
    Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062. doi:10.1016/S0140-6736(20)30566-3
    OpenUrlCrossRefPubMed
    1. Wu Z,
    2. McGoogan JM
    . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242. doi:10.1001/jama.2020.2648
    OpenUrlCrossRefPubMed
  7. ↵
    1. Lithander FE,
    2. Neumann S,
    3. Tenison E, et al.
    COVID-19 in older people: a rapid clinical review. Age Ageing 2020; 49: 501–515. doi:10.1093/ageing/afaa093
    OpenUrl
  8. ↵
    1. Oke J,
    2. Heneghan C
    . Global COVID-19 case fatality rates. CEBM Research, April 6, 2020. www.cebm.net/global-covid- 19-case-fatality-rates/ Date last accessed: May 25, 2020. Date last updated: March 17, 2020.
  9. ↵
    1. Ghani AC,
    2. Donnelly CA,
    3. Cox DR, et al.
    Methods for estimating the case fatality ratio for a novel, emerging infectious disease. Am J Epidemiol 2005; 162: 479–486. doi:10.1093/aje/kwi230
    OpenUrlCrossRefPubMed
    1. Piccininni M,
    2. Rohmann JL,
    3. Foresti L, et al.
    Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study. BMJ 2020; 369: m1835. doi:10.1136/bmj.m1835
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Michelozzi P,
    2. de'Donato F,
    3. Scortichini M, et al.
    Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020. Euro Surveill 2020; 25: pii=2000620. doi:10.2807/1560-7917.ES.2020.25.19.2000620
    OpenUrl
  11. ↵
    1. Istituto Nazionale di Statistica
    . Impatto dell'epidemia COVID-19 sulla mortalità totale della popolazione residente. www.istat.it/it/files//2020/05/Rapporto_Istat_ISS.pdf Date last accessed: May 12, 2020. Date last updated: May 4, 2020.
  12. ↵
    1. Cereda D,
    2. Tirani M,
    3. Rovida F, et al.
    The early phase of the COVID-19 outbreak in Lombardy, Italy. arXiv:2003.09320 [q-bio.PE]
  13. ↵
    1. Regione Lombardia
    . Nuova Anagrafe Regionale SSR. www.siss.regione.lombardia.it/wps/portal/site/siss/il-sistema-informativo-socio-sanitario/principali-servizi-offerti/anagrafe-regionale-degli-assistiti-e-delle-strutture Date last accessed: June 15, 2020. Date last updated: January 7, 2019.
  14. ↵
    1. Istituto Superiore di Sanità
    . FluNews – Italia. Rapporto della sorveglianza integrata dell'influenza. www.epicentro.iss.it/influenza/flunews#epi Date last accessed: July 2, 2020. Date last updated: May 8, 2020.
  15. ↵
    1. Wood SN
    . Generalized Additive Models: An Introduction with R. 2nd Edn. Boca Raton, FL, CRC/Taylor & Francis, 2017.
  16. ↵
    1. Merrill RM
    . Environmental Epidemiology: Principles and Methods. Burlington, MA, Jones & Bartlett Publishers, 2007.
  17. ↵
    1. Dalgaard P.
    Rates and Poisson regression. In: Introductory Statistics with R. Statistics and Computing. New York, NY, Springer, 2008.
  18. ↵
    1. Rivera R,
    2. Rolke W
    . Modeling excess deaths after a natural disaster with application to Hurricane Maria. Stat Med 2019; 38: 4545–4554. doi:10.1002/sim.8314
    OpenUrl
  19. ↵
    1. Ferrara P,
    2. Albano L
    . COVID-19 and healthcare systems: what should we do next? Public Health 2020; 185: 1–2. doi:10.1016/j.puhe.2020.05.014
    OpenUrl
  20. ↵
    1. Chen S,
    2. Zhang Z,
    3. Yang J, et al.
    Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet 2020; 395: 1305–1314. doi:10.1016/S0140-6736(20)30744-3
    OpenUrlCrossRefPubMed
  21. ↵
    1. European Observatory on Health Systems and Policies
    . COVID-19 Health System Response Monitor. www.covid19healthsystem.org/countries/italy/countrypage.aspx Date last accessed: July 2, 2020. Date last updated: July 1, 2020.
  22. ↵
    1. Grasselli G,
    2. Zangrillo A,
    3. Zanella A, et al.
    Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323: 1574–1581. doi:10.1001/jama.2020.5394
    OpenUrlPubMed
  23. ↵
    1. Lee SJ,
    2. Go AS,
    3. Lindquist K, et al.
    Chronic conditions and mortality among the oldest old. Am J Public Health 2008; 98: 1209–1214. doi:10.2105/AJPH.2007.130955
    OpenUrlCrossRefPubMed
  24. ↵
    1. Istituto Nazionale di Statistica
    . Mortalità in Italia. www.dati.istat.it/Index.aspx?DataSetCode=DCIS_MORTALITA1# Date last accessed: June 25, 2020.
PreviousNext
Back to top
Vol 6 Issue 3 Table of Contents
ERJ Open Research: 6 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy
Sara Conti, Pietro Ferrara, Giampiero Mazzaglia, Marco I. D'Orso, Roberta Ciampichini, Carla Fornari, Fabiana Madotto, Michele Magoni, Giuseppe Sampietro, Andrea Silenzi, Claudio V. Sileo, Alberto Zucchi, Giancarlo Cesana, Lamberto Manzoli, Lorenzo G. Mantovani
ERJ Open Research Jul 2020, 6 (3) 00458-2020; DOI: 10.1183/23120541.00458-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy
Sara Conti, Pietro Ferrara, Giampiero Mazzaglia, Marco I. D'Orso, Roberta Ciampichini, Carla Fornari, Fabiana Madotto, Michele Magoni, Giuseppe Sampietro, Andrea Silenzi, Claudio V. Sileo, Alberto Zucchi, Giancarlo Cesana, Lamberto Manzoli, Lorenzo G. Mantovani
ERJ Open Research Jul 2020, 6 (3) 00458-2020; DOI: 10.1183/23120541.00458-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Endobronchial autologous BM-MSCs in IPF patients
  • Effect of β-blockers on the risk of COPD exacerbations
  • Recurrence of symptoms after childhood LRTI
Show more Original articles

COVID-19

  • Deep learning algorithm to classify pneumonias on chest CT
  • Fucoidan restores the endothelial glycocalyx
  • Symptoms and radiology in post-acute COVID-19 syndrome
Show more COVID-19

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society